Items Tagged ‘David Knopman’
July 26, 2021
Mayo Clinic Research in the news — 7/26/2021
By Advancing the Science contributor 
Mayo Clinic expertise has a consistent footprint in the news in 2021. This week’s topics include data security and interoperability; some lesser discussed COVID-19 related topics: language development, booster vaccines for immunocompromised individuals, portable air filters; as well as early onset dementia, and the need for diversity among bone marrow donors. Vaccines are highy unlikely […]
Tags: Aaron Krych, acute kidney injury, Ahmad Nassr, antibodies, arthritis, artificial intelligence, big data, biomarkers, bone marrow transplant, Brian Weinshenker, Bruce Johnson, Bruce Sutor
July 14, 2021
Mayo Clinic research in the news — 7/12/2021
By Advancing the Science contributor
Research and expertise from Mayo Clinic have been in the news on topics from marijuana, sleep, disparities, dementia and doses of vaccine. Read more. New York Times, Can Marijuana Make You a Better Athlete? … “If you look at any test of physical performance, there’s either no data, it’s a wash, or marijuana makes it worse,” […]
Tags: addiction research, alcoholism, Alejandro Rabinstein, Alyx Porter, Alzheimer's disease, artificial intelligence, autoimmune disorder, Bhanu Kolla, breast cancer, cancer vaccine, cardiology, Center for Individualized Medicine
June 7, 2021
Mayo Clinic Research in the news — 6/7/2021
By Advancing the Science contributor
Mayo Clinic research and faculty experts are cited by media outlets on a range of topics this week including the newly-approved Alzheimer’s drug (Monday, 6/7/2021), a new treatment for multiple myeloma and another for precocious puberty, as well as remote patient monitoring and other timely topics. Alzheimer’s Drug Poses a Dilemma for the F.D.A. The […]
Tags: Alzheimer's disease, autonomic nervous system, cardiovascular medicine, Chia-Chun Chiang, clinical informatics, clinical research, clinical trials, COVID-19, Cris Ross, David Knopman, DeLisa Fairweather, FDA
June 1, 2021
Mayo Clinic Research in the News — 6/1/2021
Today’s summary reaches back an extra day, and covers acupuncture for insomnia, new artificial intelligence solutions,, carpal tunnel’s connection to to bilateral oophorectomy, sublingual vaccines and showcases wide variety of other Mayo Clinic research and research expertise. Research on inflammatory disease widens Gulf Today, 5/24/2021 An epidemiological study of Inflammatory Bowel Diseases (IBD) is being […]
Tags: acupuncture, acute kidney injury, antibiotic, artificial intelligence, Brian Lacy, cardiovascular medicine, carpal tunnel, Cheryl Willman, clinical trials, colorectal cancer, COVID-19, David Knopman
March 15, 2021
Mayo Clinic Research in the news — 3/15/2021
News stories this week about Mayo Clinic research and highlighting researchers cover several topics including research education, examining the retina to detect dementia, lumbar punctures and opioid management. State leaders stress the importance of phase II of Prairie Springs Science Center WXOW, 3/9/2021 Seven state leaders gathered at UW-La Crosse’s Crowley Hall Tuesday morning to […]
Tags: Alzheimer's disease, Amy Oxentenko, cancer, Center for Clinical and Translational Science, clinical trials, COVID-19, David Knopman, dementia, Derek Johnson, diabetes, Mayo Clinic Alix School of Medicine, Mayo Clinic Health System
March 1, 2021
Mayo Clinic Research in the news — 3/1/2021
Media coverage of Mayo Clinic research and expertise covered home cancer screening tests, youth vaping, several advancements in women’s health, COVID-19 and many other topics. Read on for excerpts and links to the articles. Health officials: “Youth vaping a serious issue” KAAL, 2/25/2021 New findings show youth vaping in Minnesota is worse than many had […]
Tags: addiction research, Alzheimer's disease, Aminah Jatoi, anaphylaxis, arthritis, basic science, bladder cancer, BRCA1, BRCA2, cancer screening, clinical research, cognitive impairment
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia
March 30, 2020
Mayo Clinic Research in the News — Week in Review 3/30/2020
In this unconventional time, we are going to offer an unconventional article, really a collection of the previous week’s news stories related to Mayo Clinic Research. Our plan – to share a brief excerpt and link to stories written by journalists around the world. Most will likely be about COVID-19, some may report findings that […]
Tags: antiviral, cardiology, clinical trials, collaboration, COVID-19, David Knopman, dementia, Gianrico Farrugia, heart attack, John Halamka, Mayo Clinic Laboratories, Mayo Clinic Proceedings
November 13, 2019
By Advancing the Science contributor
By Mass General Research Communications Staff Stroke is the leading cause of adult disability in the US, with up to 70% of stroke survivors suffering some degree of post-stroke VCID. Furthermore, some stroke subtypes carry a disproportionate burden of the disability related to stroke. We are excited to announce that, last month, the National Institute […]
Tags: aging, Clifford Jack Jr., cognitive impairment, collaboration, David Knopman, dementia, James Meschia, Jonathan Graff-Radford, Kevin Barrett, Mayo Clinic Study of Aging, neurology, Prashanthi Vemuri